Dr. Stacy Malaker’s laboratory is pioneering the field of “mucinomics,” creating advanced techniques to analyze abnormal glycosylation— the attachment of sugar molecules— in cancer-associated proteins known as mucins. Her innovative approaches have significant implications for early cancer detection and the development of glycosylation-targeted immunotherapies. Dr. Malaker’s research is poised to impact the treatment of epithelial cancers, including ovarian, breast, and colorectal carcinomas.
Projects and Grants
Leveraging Altered Glycosylation for Improved Cancer Immunotherapies
Yale University | All cancers, Ovarian cancer | 2024
